Mukul JAIN
Known title: Chief Operating OfficerCIK: 0001667593
Associated companies
Transaction History
| SENS | ▼ Sell | Tax Withholding | 16,194 | $116K | 6/15/2026 | View on chart |
| SENS | ▲ Buy | Grant | 270,759 | $0 | 5/19/2026 | View on chart |
| SENS | ▼ Sell | Tax Withholding | 13,681 | $80K | 5/15/2026 | View on chart |
| SENS | ▼ Sell | Tax Withholding | 10,317 | $65K | 11/15/2025 | View on chart |
| SENS | ▼ Sell | Tax Withholding | 58,761 | $30K | 6/16/2025 | View on chart |
| SENS | ▲ Buy | Grant | 990,688 | $0 | 5/23/2025 | View on chart |
| SENS | ▼ Sell | Tax Withholding | 260,393 | $143K | 5/15/2025 | View on chart |
| SENS | ▼ Sell | Tax Withholding | 282,546 | $79K | 11/15/2024 | View on chart |
| SENS | ▼ Sell | Tax Withholding | 132,448 | $52K | 6/15/2024 | View on chart |
| SENS | ▲ Buy | Grant | 2,204,408 | $0 | 5/23/2024 | View on chart |
| SENS | ▼ Sell | Tax Withholding | 151,796 | $76K | 5/15/2024 | View on chart |
| SENS | ▼ Sell | Tax Withholding | 266,908 | $163K | 11/15/2023 | View on chart |
| SENS | ▼ Sell | Tax Withholding | 81,861 | $63K | 6/15/2023 | View on chart |
| SENS | ▼ Sell | Tax Withholding | 217,479 | $161K | 5/15/2023 | View on chart |
| SENS | ▲ Buy | Grant | 1,380,157 | $0 | 5/15/2023 | View on chart |
| SENS | ▼ Sell | Tax Withholding | 185,273 | $232K | 11/15/2022 | View on chart |
| SENS | ▼ Sell | Open Market | 50,000 | $99K | 8/4/2022 | View on chart |
| SENS | ▼ Sell | Tax Withholding | 38,018 | $37K | 6/15/2022 | View on chart |
| SENS | ▲ Buy | Grant | 775,863 | $0 | 5/26/2022 | View on chart |
| SENS | ▲ Buy | Grant | 45,000 | $0 | 5/26/2022 | View on chart |
| SENS | ▼ Sell | Tax Withholding | 114,117 | $129K | 5/16/2022 | View on chart |
| SENS | ▼ Sell | Open Market | 150,197 | $369K | 2/11/2022 | View on chart |
| SENS | ▲ Buy | Grant | 260,483 | $0 | 2/10/2022 | View on chart |
| SENS | ▼ Sell | Open Market | 100,000 | $370K | 11/16/2021 | View on chart |
| SENS | ▼ Sell | Tax Withholding | 115,138 | $438K | 11/15/2021 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
September 30, 2026
Beta Bionics and Senseonics announce iLet-Eversense 365 integration
Beta Bionics and Senseonics announced a deal to integrate the iLet automated insulin delivery system with the Eversense 365 continuous glucose monitor. This partnership aims to provide a more seamless solution for patients managing diabetes. The news highlights a strategic move to combine two major technologies in the diabetes care market.
Beta Bionics and Senseonics announce iLet-Eversense 365 integration. Beta Bionics and Senseonics announced a deal to integrate the iLet automated insulin delivery system with the Eversense 365 continuous glucose monitor. This partnership aims to provide a more seamless solution for patients managing diabetes. The news highlights a strategic move to combine two major technologies in the diabetes care market.